Old Web
English
Sign In
Acemap
>
Paper
>
Seroprevalence of SARS-COV-2 in multiple sclerosis patients under immunomodulatory treatment in lleida (study emCOVID-19)
Seroprevalence of SARS-COV-2 in multiple sclerosis patients under immunomodulatory treatment in lleida (study emCOVID-19)
2020
J.V. Hervás García
A Gil Sánchez
C. González Mingot
L. Nogueras
L. Quibus
A. Sancho
B. Quirant
S. Peralta
M. J. Solana
C. Ramo
Eva Martínez-Cáceres
Luis Brieva
Keywords:
severe acute respiratory syndrome coronavirus 2
Seroprevalence
Virology
Coronavirus disease 2019
2019 20 coronavirus outbreak
Multiple sclerosis
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]